ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
Cet article présente des recommandations pour la prise en charge des patientes atteintes d'un cancer du sein de stade avancé
Advanced breast cancer (ABC) is a treatable but still generally incurable disease. The goals of care are to optimize both length and quality of life. Due to continuous research, several advances have been made, particularly for the human epidermal growth factor receptor 2 (HER-2)-positive and for luminal-like subtypes. Notwithstanding these advances, median overall survival of patients with ABC is still only 2–3 years, although the range is wide [1–5], and survival may be longer for patients treated in specialized institutions [6]. Implementation of current knowledge is highly variable among countries and within each country.
The use of treatment guidelines has been associated with a significant improvement in survival...
Annals of Oncology , article en libre accès, 2014